GLENMARK

Q3 result

Glenmark Pharmaceuticals Q3 Results 2025 -

declared their Q3 results on 14 Feb, 2025, revealing a significant increase in topline by 35.14%, with profit reaching ₹347.96 Cr. This marks a remarkable turnaround from the loss of ₹351.37 Cr reported during the same period in the previous fiscal year.